title: Recent advancements in the cardiovascular drug carriers.
abstract: Cardiovascular disease is the disease that affects the cardiovascular system, vascular diseases of the brain and kidney, and peripheral arterial disease. Despite of all advances in pharmacological and clinical treatment, heart failure is a leading cause of morbidness and mortality worldwide. Many new therapeutic advance strategies, including cell transplantation, gene delivery or therapy, and cytokines or other small molecules, have been research to treat heart failure. The main aim of this review article is to focus on nano carriers advancement and addressing the problems associated with old and modern therapeutics such as nonspecific effects and poor stability.
authors.affiliation: a Department of Pharmaceutics , ISF College of Pharmacy , Moga , Punjab , India.
authors.forename: Baljeet
authors.initials: B
authors.lastname: Singh
authors.affiliation: a Department of Pharmaceutics , ISF College of Pharmacy , Moga , Punjab , India.
authors.forename: Tarun
authors.initials: T
authors.lastname: Garg
authors.affiliation: a Department of Pharmaceutics , ISF College of Pharmacy , Moga , Punjab , India.
authors.forename: Amit K
authors.initials: AK
authors.lastname: Goyal
authors.affiliation: a Department of Pharmaceutics , ISF College of Pharmacy , Moga , Punjab , India.
authors.forename: Goutam
authors.initials: G
authors.lastname: Rath
mesh_terms: D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D004247:DNA / Q000008:administration & dosage; D050091:Dendrimers / Q000008:administration & dosage; D016503:Drug Delivery Systems / Q000295:instrumentation / Q000379:methods*; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D008081:Liposomes / Q000008:administration & dosage; D008823:Micelles; D045423:Microbubbles / Q000627:therapeutic use; D050997:Nanomedicine / Q000295:instrumentation / Q000379:methods*; D053758:Nanoparticles / Q000008:administration & dosage; D011673:Pulsatile Flow; D013607:Tablets; D014464:Ultrasonic Therapy
chemical_list: D002317:Cardiovascular Agents; D050091:Dendrimers; D008081:Liposomes; D008823:Micelles; D013607:Tablets; D004247:DNA
keywords: Nanoparticle; cardiovascular disease; gene therapy; nanotechnological approaches